x

Publications

Publications

Published Articles (Click here to View)

Hot papers

  1. Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513-30.
  2. Ezzati M, Bentham J, Di Cesare M, Bilano V, Bixby H, Zhou B, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-42.
  3. Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan MJ, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37-55.
  4. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378(9798):1231-43.
  5. Mente A, O'Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018;392(10146):496-506.
  6. O'Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang XY, Liu LS, et al. Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events. New England Journal of Medicine. 2014;371(7):612-23.
  7. Di Cesare M, Bentham J, Stevens GA, Zhou B, Danaei G, Lu Y, et al. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377-96.
  8. Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, et al. Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. Phytotherapy Research. 2016;30(9):1540-8.
  9. Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Health. 2019;7(6):E748-E60.
  10. Bixby H, Bentham J, Zhou B, Di Cesare M, Paciorek CJ, Bennett JE, et al. Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature. 2019;569(7755):260-+.
  11. Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A, Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-73.
  12. Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795-808.
  13. Miller V, Mente A, Dehghan M, Rangarajan S, Zhang XH, Swaminathan S, et al. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet. 2017;390(10107):2037-49.
  14. Roshandel G, Khoshnia M, Poustchi H, Hemming K, Kamangar F, Gharavi A, et al. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet. 2019;394(10199):672-83.
  15. Lear SA, Hu WH, Rangarajan S, Gasevic D, Leong D, Iqbal R, et al. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet. 2017;390(10113):2643-54.
  16. Bentham J, Cesare M, Stevens GA, Zhou B, Bixby H, Cowan M, et al. A century of trends in adult human height. Elife. 2016;5.
  17. Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, et al. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries. New England Journal of Medicine. 2014;371(9):818-27.
  18. Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet. 2016;387(10013):61-9.
  19. Dehghan M, Mente A, Zhang XH, Swaminathan S, Li W, Mohan V, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017;390(10107):2050-62.
  20. Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, et al. Association of Urinary Sodium and Potassium Excretion with Blood Pressure. New England Journal of Medicine. 2014;371(7):601-11.
  21. Dehghan M, Mente A, Rangarajan S, Sheridan P, Mohan V, Iqbal R, et al. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2018;392(10161):2288-97.
     

Congress papers

  1. Jamshidnia M, Asgary S, Rafieian-Kopaei M. Establishment Of Pcr Conditions For Determination Of Silybum Marianum Genetic Diversity Using Issr Marker. Acta Horticulturae: International Society For Horticultural Science; 2020. P. 395-401.
  2. Sadeghi M, Roohafza H, Talaei M. Association Between Plasma Lipid Disorders And 12-Years Cardiovascular Events - Isfahan Cohort Study (Ics). Atherosclerosis Supplements. 2018;32:49-50.
  3. Roohafza H, Sadeghi M. Changes Of Inflammatory Markers' Level During Hospitalization In Patients With Acute Myocardial Infarction With And Without Depression. Atherosclerosis Supplements. 2018;32:73-4.
  4. Hosseini N, Talaei M, Marshall T, Sadeghi M, Oveisgharan S, Sarrafzadegan N. Risk Of Cardiovascular Disease In Treated And Untreated Individuals With Hypertension: The Isfahan Cohort Study. Journal Of Hypertension. 2018;36:E3-E.
  5. Yusufali Am, Khatib R, Islam S, Alhabib Kf, Bahonar A, Swidan Hm, Et Al. Prevalence, Awareness, Treatment And Control Of Hypertension In Four Middle East Countries. Journal Of Hypertension. 2017;35(7):1457-64.
  6. Yusufali A, Khatib R, Islam S, Alhabib K, Kelishadi R, Rangarajan S, Et Al. Prevalence, Awareness, Treatment, And Control Of Hypertension In The Middle East: Results From The Prospective Urban Rural Epidemiology (Pure) Study. Journal Of Hypertension. 2016;34:E551-E.
  7. Dehkordi Aa, Nayeri H, Naderi Ga, Dinani Nj, Boshtam M. Lipoproteins And Lipid Metabolism: Hdl. Interleukin-6 Reduces Paraoxonase-1 Activity In A Dose-Dependent Manner; Evidence For A Potential Novel Lipoprotein-Based Modulatory Mechanism. Atherosclerosis. 2016;252:E113-E4.
  8. Masoudkabir F, Kassaian Se, Sezavar H, Alavinia Se, Pourmoghaddas A, Kojouri J, Et Al. Clinical Characteristics, Management, And 1-Year Outcomes Of Patients With Acs In Iran: The Iranian Project For Assessment Of Coronary Events2 (Ipace2). Cardiology. 2015;132:116-7.
  9. Gharipour M, Sadeghi M. Effect Of Age On The Phenotype Of Metabolic Syndrome In Developing Country. European Journal Of Cardiovascular Nursing. 2015;14:S54-S.
  10. Saeidi M. Cardiac Rehabilitation In Cardiac Patients With Metabolic Syndrome. Journal Of The American College Of Cardiology. 2014;64(16):C209-C10.
  11. Abdi S, Dorranian D, Naderi G, Razavi Ae, Moazen E. Possible Interaction Of Extremely Low Frequency Electromagnetic Fields With Atherosclerosis Promotion And Progression In Human, An Invitro Investigation. Cardiovascular Research. 2014;103.
  12. Saeidi M, Mostafavi S. Effects Of A Comprehensive Cardiac Rehabilitation Program On Quality Of Life In Patients With Coronary Artery Disease. Heart. 2013;99:E140-E1.
  13. Sahebkar A, Emami Sa, Asgary S, Naderi Ga, Ardekani Mrs, Kasher T, Et Al. Antioxidant Activity Of Essential Oils From Cupressus Species Against Oxidation Of Ldl. Circulation. 2012;125(19):E912-E3.
  14. Sadeghi M, Pourmoghaddas Z, Roohafza H, Sarrafzadegan N. Body Fat Distribution, And Serum Lipids In Patients With And Without Coronary Heart Disease. Circulation. 2012;125(19):E910-E.
  15. Sadeghi M, Pourmoghaddas Z, Roohafza H, Sarrafzadegan N. Association Of Apolipoprotein B, Apolipoprotein A, And The Apolipoprotein B/Apolipoprotein A Ratio With Body Fat Indicators. Circulation. 2012;125(19):E911-E.
  16. Razavi Ae, Basati G, Ani M, Naderi G, Pourfarzam M, Boshtam M. Relationship Between Hdl Mean Size And Mpo/Pon1 Ratio In Unstable Cad Patients. Circulation. 2012;125(19):E857-E.
  17. Mirzaei M, Soltani Mh, Ghahi Ng, Namayandeh M. Sodium And Potassium Intake Of Urban Dwellers In Yazd-Iran. Circulation. 2012;125(19):E882-E3.
  18. Khosravi A, Kelishadi R, Pourmoghaddas M, Sarrafzadegan N, Boshtam M, Nouri F, Et Al. The Role Of Community-Based Lifestyle Intervention On Salt Intake And Blood Pressure In Iran. European Heart Journal. 2012;33:299-300.
  19. Farsani Ak, Rowzati M, Gharipour M, Khosravi Z, Sarrafzadegan N. Hypertension Control In Industrial Impact Of Shimsco Study In Iran. European Heart Journal. 2012;33:620-.
  20. Abdi S, Dorranian D, Razavi Ae, Naderi G, Boshtam M. Effect Of Dc Magnetic Fields On Ldl Oxidation. Circulation. 2012;125(19):E858-E.
  21. Razavi Ane, Ani M, Naderi Ga, Pourfarzam M. The Relationships Between Hdl Mean Particle Size And Serum Paraoxonase Activity. Clinical Biochemistry. 2011;44(13):S49-S.
  22. Kabir A, Sarrafzadegan N, Amini A, Aryan Rs, Kerahroodi Fh, Rabiei K, Et Al. Impact Of Cardiac Rehabilitation On Metabolic Syndrome In Iranian Patients With Coronary Heart Disease. American Journal Of Epidemiology. 2011;173:S171-S.
  23. Haghjoo S, Haghdoost F, Keyhanian K, Samety Aa, Loghmani P, Rafiee L, Et Al. Association Between Heme Oxigenase-1 Gene Promoter Polymorphisms And Metabolic Syndrome In Iranians. Clinical Biochemistry. 2011;44(13):S302-S3.
  24. Basati G, Ziaaldin Ss, Movahedian A, Pourfarzam M, Sarrafzadegan N. The Association Of Plasma Leptin And Homocysteine Levels With The Severity Of Coronary Artery Disease. Clinical Biochemistry. 2011;44(13):S1-S.
  25. Basati G, Razavi Ane, Ani M, Naderi Ga, Boshtam M. Association Of The Plasma Myeloperoxidase Level With Paraoxonase-1 Activity In Unstable Coronary Artery Disease. Clinical Biochemistry. 2011;44(13):S125-S.
  26. Basati G, Naderi Ga, Boshtam M, Razavi Ane, Sadeghi M. Circulating Activity Of Secretory Phospholipase A2 And Paraoxonase-1 In Relation To The Severity Of Coronary Artery Disease. Clinical Biochemistry. 2011;44(13):S46-S.
  27. Toghianifar N, Sarrafzadegan N, Ramezani Ma, Bahonar A, Nouri F. Smoking Cessation Advice Among Hypertensive Patients In A Population-Based Sample Of Iranian Adults (Ihhp). Circulation. 2010;122(2):E277-E.
  28. Sarrafzadegan N, Sadri G, Melek-Afzali H. Effect Of A 6-Year Comprehensive Community-Based Program On Cardiovascular Risk Factors: Experiences From Demonstration Study In A Developing Country. Circulation. 2010;122(2):E81-E.
  29. Sarrafzadegan N, Rabiei K, Zarfeshani S. Lessons Learned From Failures: Experiences Of Demonstration Program For Cardiovascular Disease Prevention And Control. Circulation. 2010;122(2):E358-E.
  30. Sarrafzadegan N, Rabiei K, Sadri G. Process Evaluation Of Community-Based Interventions For Prevention And Control Of Cardiovascular Diseases: A Neglected Area Of Evaluation. Circulation. 2010;122(2):E179-E80.
  31. Sadeghi M, Sarafzadegan N. Comprehensive Community Interventions To Prevent Cardiovascular Disease In A Developing Country. Circulation. 2010;122(2):E178-E.
  32. Sadeghi M, Roohafza H. Is Lipoprotein (A) A Predictor Of Coronary Artery Disease Severity? Circulation. 2010;122(2):E270-E.
  33. Roohafza H, Sadeghi M. Triggering Effect Of Acute Life Events On Acute Coronary Syndrome: Aleace, A Case-Control Study. Circulation. 2010;122(2):E182-E.
  34. Rafiei M, Entezari H, Boshtam M. Association Between Food Insecurity, And Cvd And Its Risk Factors In Iran. Atherosclerosis Supplements. 2010;11(2):210-.
  35. Nayeri H, Naderi Ga, Asgary S, Pakmehr F, Sadeghi M, Javadi E. Correlation Between Lag Time Of Ldl To In Vitro Oxidation And In Vivo Ox-Ldl In The Patients With Cad. Atherosclerosis Supplements. 2010;11(2):130-.
  36. Mohammadifard N, Sajjadi F, Maghroon M, Alikhasi H. Effect Of Isfahan Healthy Heart Program Interventions On Nutrition Behaviours In A Developing Country Setting. Circulation. 2010;122(2):E80-E1.
  37. Kelishadi R, Zemel M. Three-Year Study On The Effects Of A Trial Of A Dairy-Rich Diet On Body Composition, Insulin Resistance, And Components Of The Metabolic Syndrome Among Obese Prepubescent Children. Circulation. 2010;122(2):E188-E9.
  38. Kelishadi R, Hashemipour M. Can A Trial Of Motivational Lifestyle Counseling Be Effective For Controlling Childhood Obesity And The Associated Cardiometabolic Risk Factors? Circulation. 2010;122(2):E189-E.
  39. Gharipour M, Sarrafzadegan N, Toghianfar N, Mackie M, Noori F. Metabolic Syndrome: Patient Compliance With Drug Treatment (Isfahan Healthy Heart Study). Circulation. 2010;122(2):E139-E.
  40. Boshtam M, Moshtaghian J, Naderi G, Asgary S. Citrus Limon Burm F. Can Change Affinity Of Ldl And Ox-Ldl To Their Receptors In Rabbits With Atherogenic Diet. Atherosclerosis Supplements. 2010;11(2):145-.
  41. Boroujeni Fz, Wirza R, Maskon O, Khosravi A, Khalilian M, Editors. An Improved Seed Point Detection Algorithm For Centerline Tracing In Coronary Angiograms2010.
  42. Asgary S, Shamsi F, Kazemi S, Adelneia A, Rafieian M. Pretreatment Effect Of Cornus Mas L. On Alloxan-Induced Diabetes In Rats. Atherosclerosis Supplements. 2010;11(2):209-10.
  43. Setorki M, Asgary S, Rohani Ah, Eidi A. Acute Effects Of High-Fat Meals Enriched With Vinegar On Postprandial Endothelial Function. Atherosclerosis Supplements. 2009;10(2).
  44. Schwandt P, Kelishadi R, Haas G, Liepold E. The Metabolic Syndrome According To The New Idf Definition In German And Iranian Youth. Atherosclerosis Supplements. 2009;10(2).
  45. Rafiei M, Boshtam M, Moshtaghian J, Naderi G. Effect Of Citrus Limon Burm F. On Lipids And Lipoproteins In Rabbits With Atherogenic Diet. Atherosclerosis Supplements. 2009;10(2).
  46. Poursafa P, Kelishadi R. Effects Of A Lifestyle Modification Trial Among Phenotypically Obese Metabolically Normal And Phenotypically Obese Metabolically Abnormal Adolescents. European Heart Journal. 2009;30:589-.
  47. Nayeri H, Naderi G, Asgry S, Sadeghi M. Correlation Between Lag Time Of Ldl To In Vitro Oxidation And In Vivo Ox-Ldl In The Patients With Cad. Atherosclerosis Supplements. 2009;10(2).
  48. Mohammadifard N, Kelishadi R, Sajjadi F, Maghroon M. Effect Of Of Isfahan Healthy Heart Program Interventions On Nutritional Behaviour Of Iranian Adults. Atherosclerosis Supplements. 2009;10(2).
  49. Moaddab Mh, Kelishadi R, Hashemipour M, Amini M. The First Report On The Prevalence Of Impaired Fasting Glucose And Type 2 Diabetes In A Population-Based Sample Of Overweight/Obese Children In The Middle East. Hormone Research. 2009;72:329-.
  50. Khosravi A, Mehr Gk, Poormoghadas M, Tavasoli A. Preprocedural C-Reactive Protein Predictive Value In Angiographic In-Stent Restenosis After Coronary Stent Placement In Patients With Stable Angina. Atherosclerosis Supplements. 2009;10(2).
  51. Kelishadi R, Cook S. Correlation Between The Metabolic Syndrome And Hepatic Disorders Among Overweight/Obese Children And Adolescents. European Heart Journal. 2009;30:663-.
  52. Gharipour M, Sarrafzadegan N, Siadat Z, Maghroun M, Abdolvand A. Metabolic Syndrome Epidemiology Based On Socioeconomic Status: Cross Sectional Study Among Iranian Adult Population (Ihhp Study). Atherosclerosis Supplements. 2009;10(2).
  53. Boshtam M, Naderi G, Moshtaghian J. Effect Of Citrus Limon Burm F. On Ldl And Ox-Ldl Affinity To Their Receptors In Rabbits With Atherogenic Diet. Atherosclerosis Supplements. 2009;10(2).
  54. Asgary S, Rahimi P, Madani H, Mahzouni P, Kabiri N, Dastjerdi Hm. Antidiabetic Effect Of Hydroalcoholic Extract Of Carthanus Tinctorius L. In Alloxan-Induced Diabetic Rats. Pharmaceutical Biology. 2009;47:28-.
  55. Asgary S, Nazari B, Sarrafzadegan N, Saberi S, Azadbakht L, Esmaillzadeh A. Trans Fatty Acid Content Of Some Iranian Commercial Food Products. Atherosclerosis Supplements. 2009;10(2).
  56. Asgary S, Kabiri N, Madani H, Mahzoni P, Rahimi P. Effects Of Hydroalcoholic Extract Of Hypericum Perforatum On Selected Traditional And Novel Biochemical Risk Factors Of Cardiovascular Diseases And Atherosclerotic Lesions In Hypercholesterolemic Rabbits: A Comparison Between The Extract And Lovastatin. Pharmaceutical Biology. 2009;47:12-.
  57. Asgary S, Kabiri N, Madani H, Mahzoni P, Rahim P. Regression Of Hypercholesterolemic Atherosclerosis In Rabbits By Hydroalcoholic Extracts Of Hypericum Perforatum. Atherosclerosis Supplements. 2009;10(2).
  58. Schwandt P, Kelishadi R, Haas G. First Reference Curves Of Waist Circumference For German Children: The Pep Family Heart Study. Atherosclerosis Supplements. 2008;9(1):142-.
  59. Kelishadi R, Schwandt P, Hosseini M, Haas Gm. An Anthropometric Comparison Between 3-11-Year Old Children Of A Western And A Non-Western Population. Atherosclerosis Supplements. 2008;9(1):223-.
  60. Kelishadi R, Hashemi M, Mohammadifard N, Asgary S, Khavarian N. Association Of Changes In Oxidative And Proinflammatory States With Changes In Vascular Function After A Lifestyle Modification Trial Among Obese Adolescents. Circulation. 2008;118(12):E266-E.
  61. Kelishadi R, Badiei Z. Factors Associated With The Cord Blood Lipid Profile: Baseline Data Of A Birth Cohort Study. Circulation. 2008;118(12):E443-E4.
  62. Gharipour M, Baghaie A, Tavasoli A, Farhad M, Rabiei K. Pharmacological Treatment, Lifestyle Modification And Awareness In Coronary Artery And Cerebrovascular Disease. Journal Of Hypertension. 2008;26:S54-S.
  63. Asgary S, Rahimi P, Madani H, Mahzouni P, Dinani Nj. Effect Of Hydroalcoholic Extracts Of Jugulans Regia On Blood Sugar In Diabetes-Induced Rats. Circulation. 2008;118(12):E276-E.
  64. Asgary S, Dinani Nj, Mahzouni P. Dietary Supplementation With Artemisia Sieberi Reduce Atherosclerosis In Hypercholesterolemic Rabbits. Circulation. 2008;118(12):E276-E.
  65. Asgari S, Fatahi Z, Naderi Gh, Hosseini M, Amini F. Different Methods Of Oxidative Modification Of Ldl And Immune Response In Atherosclerosis. Atherosclerosis Supplements. 2007;8(1):89-.
  66. Naderi Gh, Asgary S, Oroojy H, Bashardoost N. The Effect Of Opium Addiction On The Plasma Levels Of Fibrinogen, Factor Vii And Crp. Atherosclerosis Supplements. 2006;7(3):394-5.
  67. Asgary S, Barkhordari Hr, Hojjat H, Naderi Gh, Dashti G. Is Morphine Use Effective In Preventing Atherosclerosis In Animals On Normal And High-Cholesterol Diet? Atherosclerosis Supplements. 2006;7(3):395-.
  68. Ansari R, Abdar M, Kelishadi R, Khosravi A. To Determine The Prevalence Of Phenotypes Of Metabolic Syndrome Among Heypertensive Patients In Central Areas Of Iran. Atherosclerosis Supplements. 2006;7(3):426-.
  69. Kelishadi R, Sadri G, Sabet B. Smoking And Its Health Hazards In Iranian Adolescents. Pediatric Research. 2004;55(4):4a-A.
  70. Rafiei M, Boshtam M, Golshadi I, Ani M. Long Term Effects Of Oral Vitamin E Supplement In Type Ii Diabetic Patients. Atherosclerosis Supplements. 2003;4(2):84-.
  71. Derakhshan E, Derakhshan R, Derakhshan M, Ansarian H. Do Iranian Students Of Health School Really Have Low Cardiovascular Risk Factors? Atherosclerosis Supplements. 2003;4(2):87-.
  72. Naderi Ga, Messripour M, Asgary S. Inhibition Of Lysine Residue Of D2-Dopamine Receptors Results Decreased Dopaminergic And Increased B-Adrenergic Effects. Journal Of Molecular And Cellular Cardiology. 2001;33(6):A82-A.
  73. Kelishadi R, Soleimani Ah, Alikhassi H. Evaluation Of Daily Dietary Intake And Serum Level Of Zinc And Copper In Children Of High Risk Families For Premature Cardiovascular Disease. Journal Of Molecular And Cellular Cardiology. 2001;33(6):A58-A.
  74. Kehshadi R, Hashemipoor M. The Status Of Major Risk Factors Of Atherosclerosis In Children And Adolescents Of Isfahan. Atherosclerosis. 1998;136:S50-S.
     

Book

  1. Sesterterpenoids 
  2. Cancers of the endocrine system, Cancer Genetics and Psychotherapy
  3. Effect of dairy products consumption on heart health and cardio-metabolic risk factors
  4. Participation Compliance and Outcomes of Outpatient Cardiac Rehabilitation Programs among Women in Low Resource Settings
  5. First Book-IHHP
  6. Second Book-IHHP
  7. Third Book-IHHP
  8. Medical Epidemiology
  9. Healthy Cooking for a Health Heart
  10. Healthy Heart with ...
  11. Heart Friends Around the World
  12. The story of Heart
  13. An introduction to Isfahan Cardiovascular Research Center
  14. Childhood Nutrition in Health & Disease
  15. Comparing various physical activities ... (Isfahan Healthy Heart Program)
  16. Pour PM, Behzad S, Asgari S, Khankandi HP, Farzaei MH. Sesterterpenoids. Silva AS, Nabavi SF, Saeedi M, Nabavi SM, editors2020. 347-91 p.
  17. Tabatabaiefar MA, Moridnia A, Shariati L. Cancers of the endocrine system.  Cancer Genetics and Psychotherapy: Springer International Publishing; 2017. p. 499-530.
  18. Khosravi-Boroujeni H, Sarrafzadegan N. Effect of dairy products consumption on heart health and cardio-metabolic risk factors. In: Watson RR, Zibadi S, editors. Handbook of Nutrition in Heart Health. Human Health Handbooks. 142017. p. 445-65. 
  19. Sarrafzadegan N, Rabiei K. Participation Compliance and Outcomes of Outpatient Cardiac Rehabilitation Programs among Women in Low Resource Settings. Halliday JT, editor2010. 185-97 p.

 

Journal

- ARYA Journal

Prepared at Isfahan University of Medical Sciences